Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
2024 Paris Olympics TV schedule
Recommended
On the Record: Digging into the Deven case
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Ltd ADR
(NY:
TAK
)
13.72
-0.16 (-1.15%)
Streaming Delayed Price
Updated: 11:36 AM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ltd ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Vertex Pharma Stumbles In Rare-Disease Effort, Buoying Rival Arrowhead Pharma
June 10, 2021
Vertex Pharmaceuticals scrapped development of a rare-disease treatment Thursday that appeared unlikely to benefit patients, and VRTX stock plunged.
Via
Investor's Business Daily
Blueprint for Access to Innovative Healthcare Episode 1: Awareness and Prevention
June 10, 2021
SOURCE: Takeda
Via
3BL Media
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Global Diversity, Equity, and Inclusion Week at Takeda
June 08, 2021
SOURCE: Takeda
Via
3BL Media
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
June 07, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
How Significant Are Moderna's Asian Regulatory Wins?
June 05, 2021
The biotech is poised to profit in both Japan and South Korea.
Via
The Motley Fool
Exposures
COVID-19
A Better Switch
June 04, 2021
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.
Via
Talk Markets
Fan Hit
June 03, 2021
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.
Via
Talk Markets
Wonder Products
June 02, 2021
Meme is alive and well.
Via
Talk Markets
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
June 01, 2021
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...
Via
Benzinga
Exposures
Product Safety
New New Deal Worries
May 27, 2021
Nio is up 1.4% today on another round of Meme buying.
Via
Talk Markets
Good Times For Gold
May 26, 2021
Gold is rising some more, in part as an alternative to crypto.
Via
Talk Markets
Sterling At Five-Year High
May 25, 2021
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.
Via
Talk Markets
Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection
May 24, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot’s efficacy waned over time but...
Via
Benzinga
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
May 22, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Worldwide Upbeat
May 21, 2021
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review
May 21, 2021
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The...
Via
Benzinga
Exposures
Product Safety
Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan
May 21, 2021
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
May 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Is BioCryst a Good Stock to Buy Now?
May 21, 2021
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
Via
The Motley Fool
Exposures
Product Safety
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Better Mood Day
May 20, 2021
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.
Via
Talk Markets
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda FY20 Profit Surges, Revenue Drops; Guides For Weak FY21 Profit
May 11, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported an FY20 net profit of ¥376 billion, a 750% Y/Y increase, reflecting gains on non-core asset sales and...
Via
Benzinga
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
May 14, 2021
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...
Via
Benzinga
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
May 11, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares
May 12, 2021
Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...
Via
Benzinga
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
May 10, 2021
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.